Lara Kujtan
Overview
Explore the profile of Lara Kujtan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma P, Mahadevia H, Donepudi S, Kujtan L, Gustafson B, Ponvilawan B, et al.
Clin Lung Cancer
. 2024 May;
25(5):479-482.
PMID: 38777674
No abstract available.
2.
Buzard B, Douglass L, Gustafson B, Buckley J, Roth M, Kujtan L, et al.
World J Gastrointest Oncol
. 2023 Nov;
15(10):1829-1834.
PMID: 37969405
Background: Although common in lung cancer, somatic epidermal growth factor receptor () mutations are rarely found in colorectal cancer, occurring in approximately 3% of cases. Treatment with anti-EGFR antibodies is...
3.
Mahadevia H, Kujtan L, Roth M, Sharma P, Buckley J, Ewing E, et al.
Case Rep Oncol
. 2023 Oct;
16(1):784-790.
PMID: 37900851
We present 2 cases of cancer of unknown origin in which RNA-based cancer classification testing provided vital insight and directed treatment management. The tissue of origin could not be determined...
4.
Kujtan L, Subramanian J
Transl Lung Cancer Res
. 2023 Sep;
12(8):1826-1829.
PMID: 37691875
No abstract available.
5.
Kujtan L, Kancha R, Gustafson B, Douglass L, Ward C, Buzard B, et al.
Expert Rev Anticancer Ther
. 2022 Jan;
22(2):203-213.
PMID: 35034561
Introduction: Immune checkpoint inhibitors (ICIs) have revolutionized treatment for patients with non-small lung cancer (NSCLC). Currently approved ICIs are monoclonal antibodies that target programmed death receptor 1 (PD-1), its ligand...
6.
Albawaliz A, Bahaj W, Abughanimeh O, Noman A, Kujtan L
Cureus
. 2019 Jul;
11(5):e4734.
PMID: 31355093
Mixed cryoglobulinemia (MC) is well known for its association with chronic hepatitis C virus (HCV) infection. However, it has also been linked to autoimmune disorders and hematological malignancies, particularly of...
7.
Kujtan L, Subramanian J
Expert Rev Anticancer Ther
. 2019 Mar;
19(7):547-559.
PMID: 30913927
: Epidermal growth factor receptor () mutations are well-described drivers of non-small cell lung cancer (NSCLC) and EGFR tyrosine kinase inhibitors (TKIs) have become key components of the NSCLC front-line...
8.
Ahmed Z, Kujtan L, Kennedy K, Wood V, Schomas D, Subramanian J
Cancer Med
. 2019 Feb;
8(4):1500-1507.
PMID: 30790468
The standard of care treatment for locally advanced nasopharyngeal carcinoma (NPC) includes both chemotherapy and definitive radiation. However, there are limited data on the optimal management of stage II NPC....
9.
Kujtan L, Hussain A, Subramanian J, Masood A
Curr Opin Oncol
. 2018 Mar;
30(3):197-202.
PMID: 29538042
Purpose Of Review: Recent advances in next-generation sequencing have allowed for detailed molecular analysis of urothelial carcinomas, with potentially significant clinical implications for personalized treatment. Our objective in this review...
10.
Glazyrin A, Patel C, Kujtan L, Madhusudhana S
Acta Haematol
. 2018 Feb;
139(2):84-88.
PMID: 29408811
Low-grade follicular lymphomas are genetically characterized by the translocation t(14; 18)(q32;q21) with BCL2 gene rearrangements. Marginal zone lymphomas are often associated with translocations or transcriptional deregulations of the MALT gene....